Fiche centre
The First Affiliated Hospital of Zhengzhou University
Zhengzhou — China
Essais liés12clinical trials
VilleZhengzhoulocalisation
PaysChinalocalisation
SourcelocaleCSV/MySQL
Informations
centreSynchronisé depuis ClinicalTrials.gov — NCT07732309
Essais cliniques associés
12| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| ZL-1310 | Cancer | Phase 3 | NCT07218146 | A Study of ZL-1310 Versus Investigator's Choice of Therapy in Participants With Relapsed Small Cell Lung Cancer (DLLEVATE) | RECRUITING |
| Giredestrant | Cancer | Phase 3 | NCT06065748 | A Study to Evaluate Efficacy and Safety of Giredestrant Compared With Fulvestrant (Plus a CDK4/6 Inhibitor), in Participants With ER-Positive, HER2-Negative Advanced Breast Cancer Resistant to Adjuvant Endocrine Therapy (pionERA Breast Cancer) | ACTIVE_NOT_RECRUITING |
| Sotorasib | Cancer | Phase 3 | NCT05920356 | A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202) | RECRUITING |
| Cizutamig | Myasthénie | Phase 1 | NCT07215650 | Clinical Study of Cizutamig in Generalized Myasthenia Gravis (gMG) | RECRUITING |
| Cizutamig | Lupus | Phase 1 | NCT07215663 | Clinical Study of Cizutamig in Systemic Lupus Erythematosus | RECRUITING |
| Obinutuzumab | Cancer | Phase 3 | NCT06084936 | GLOBRYTE — A Study to Evaluate Glofitamab as a Single Agent vs. Investigator's Choice in Participants With Relapsed/Refractory Mantle Cell Lymphoma | RECRUITING |
| Recombinant Human Serum Albumin | Alzheimer | Phase 1 | NCT06489015 | Recombinant Human Serum Albumin in the Treatment of Mild-to-moderate AD (Alzheimer's Disease) Exploratory Clinical Trial | COMPLETED |
| Equecabtagene Autoleucel Injection (Eque-cel) | Myopathies | Phase 1/2 | NCT07752264 | A Phase I/II Study of Eque-cel in Subjects Withimmune-mediated Necrotizing Myopathy | NOT_YET_RECRUITING |
| Cenerimod 4 mg | Lupus | Phase 2 | NCT07266090 | A Study to Evaluate the Safety,Tolerability,Pharmacokinetics and Pharmacodynamics of Cenerimod in Adult Chinese Participants With Moderate-to-severe Systemic Lupus Erythematosus (SLE) | ACTIVE_NOT_RECRUITING |
| ATG-201 | Lupus | Phase 1 | NCT07732309 | ATTRACT — A Study of ATG-201 in Adult Participants With Autoimmune Diseases | NOT_YET_RECRUITING |
| Yangxue Qingnao Granules (Pills) | Migraine | À vérifier | NCT05334927 | CHAIRS — China HeadAche DIsorders RegiStry | RECRUITING |
| UX-GIP001 | Épilepsie | Phase 1 | NCT07572812 | A Phase I Clinical Trial of UX-GIP001 in the Treatment of Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy | NOT_YET_RECRUITING |